BPG is committed to discovery and dissemination of knowledge
Citation
Kong Y, Dong Q, Jin P, Li MY, Ma L, Yi QJ, Miao YE, Liu HY, Liu JG. Inetetamab combined with S-1 and oxaliplatin as first-line treatment for human epidermal growth factor receptor 2-positive gastric cancer. World J Gastroenterol 2024; 30(40): 4367-4375 [PMID: 39494102 DOI: 10.3748/wjg.v30.i40.4367]
Please LOGIN to submit a new comment.